The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...

The study, called the ABRA trial, was led by King’s College London researchers and published in The Lancet Respiratory ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...

For the first time in 50 years, a new treatment has been found to improve care for people experiencing asthma or COPD ...

Researchers say they have found the first new treatment for asthma attacks in 50 years.  The injection dampens part of the ...